Healthcare & Life Sciences News

FOCUS Investment Banking Represents Microconsult Inc. in Sale to Certified Laboratories

Microconsult, Inc. has been acquired by Certified Group Washington, DC, (June 4, 2021) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, announced today that Microconsult, Inc., a Carrollton, Texas-based industry leader in cosmetic, supplement and personal care product testing, has been acquired by Certified Laboratories, a Melville, New York-based operator of food, supplements, cosmetic, and personal care laboratories. FOCUS represented Microconsult in this transaction.
Photo: Eric Yetter and Andy Snyder

FOCUS Investment Banking Announces Merger of Physicians First to Enhance and Expand Healthcare Practice

Washington, DC, (May 10, 2021) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that Physicians First, a Nashville, Tennessee-based boutique investment banking firm focused on healthcare, has merged its practice into FOCUS. Physicians First founders Eric Yetter and Andy Snyder are joining FOCUS as Managing Directors. Yetter will lead the FOCUS Healthcare Team.

Behavioral Health Report – Q1 2021 Acquisition Activity and Outlook

Transaction Volume Continues to Increase Across Behavioral Health

The first quarter of 2021 delivered 38 reported behavioral health transactions, an increase over any quarter in 2020. We expect some of this activity reflects deals that were delayed due to COVID-19. However, we generally expect high deal flow throughout 2021, supported by increasing private equity interest, a favorable government, and a seller pool that is ready to transact.

Dermatology Report – Q1 2021 Acquisition Activity and Outlook

Core Dermatology Buyers Remain Active to Start 2021. Window of Opportunity May Be Starting to Close for Smaller Practices.

The first quarter of 2021 delivered five reported dermatology practice acquisitions. This activity decline may signal that the window of opportunity for small practice deals may be starting to close. Indeed, dermatology consolidation is now in its tenth year. However, Schweiger, Epiphany, and Anne Arundel continued to acquire smaller add-on practices and grow their platforms.

ENT & Allergy Report – Q1 2021 Acquisition Activity and Outlook

Private Equity Interest in ENT & Allergy Practices Accelerates. Expect Increasing Opportunity for Large Practice Sellers.

The first quarter of 2021 delivered five reported ENT practice acquisitions marking the most active three-month M&A period we have seen in the specialty. Notably, Audax Private Equity formally named its portfolio company “Elevate ENT” and expanded into Texas with the major acquisition of Texas ENT Specialists. While the next quarter may not produce as many deals, activity should remain high throughout this year.

Gastroenterology Report – Q1 2021 Acquisition Activity and Outlook

As Predicted, Gastroenterology Acquisition Activity Surges to New High in Q1 2021 – Major Opportunity for Selling Physicians

The first quarter of 2021 delivered nineteen gastroenterology practice acquisitions, marking an enormous surge of M&A activity within the specialty. To put that into context, the past three months had more acquisitions than the entire year of 2020. We expect that higher level of activity to continue as GI moves through the expansion lifecycle stage.